2 Top Dividend Stocks to Buy Now and Hold For a Decade

Pfizer's strategy that will help it rebound from recent struggles is in full motion. It says a lot that the company continues ...
Fierce Pharma

Pfizer reported an ATTR sales decline in the US. Should newer market entrants Alnylam and BridgeBio worry?

The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...
Zacks Investment Research on MSN

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
Seeking Alpha

Pfizer: Tracking Well Above The Industry

Despite Wall Street's continued conservatism regarding its business prospects, Pfizer beat analysts' expectations for the second quarter of 2024. In addition to the raised full-year 2024 guidance, the ...

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

And one of them is pharmaceutical giant Pfizer (NYSE: PFE). Now, with a major step along the path to entering this ...
Morningstar

Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts

We are holding steady to our fair value estimate and wide moat rating for Pfizer PFE following first-quarter results that largely matched our expectations. The company is tracking well to meet its ...

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...
FiercePharma

UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management accountable” for ...
Morningstar

Pfizer Earnings: Cost-Cutting Remains on Track to Adapt to COVID-19 Product Sale Declines

Pfizer PFE reported fourth-quarter earnings ahead of our expectations, largely due to lower-than-expected research and development spending. However, we don’t expect this will continue, so there is no ...
Nasdaq

Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer

NEW HAVEN, Conn. and NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Nasdaq

Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza

NEW YORK and MAINZ, GERMANY, DECEMBER 9, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the companies have received Fast Track Designation from the U.S. Food and Drug ...
Business Wire

Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma | Business Wire

“We look forward to working with our partners at Merck KGaA, Darmstadt, Germany, on the development of avelumab in patients with relapsed and refractory Merkel cell carcinoma,” said Dr. Mace ...